Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiology
Dow AgroSciences applauds new study underscoring need to increase trans fat-free oils
May 18th, 2006
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (DOW), applauded a major review article in the April 13, 2006 issue of the New England Journal of Medicine (NEJM). The article reviewed the latest evidence concerning the presence of trans fats in the American diet and the negative impact of trans fats on human health. Importantly, the authors calculated that up to 228,000 (19%) of coronary heart disease (CHD) events could be avoided if trans fats were replaced by carbohydrates, and that CHD risks could be reduced even more if partially hydrogenated oils are replaced by trans-free oils with a healthy profile. The...
Source: Biotech Business Week (2006-05-18)
|
